Heartflow CMO Campbell Rogers sells $380k in shares

Campbell Rogers, Chief Medical Officer at Heartflow Inc., sold approximately 9,219 shares of the company's stock on August 17, 2026, for a total of $380,099. This followed the exercise of stock options, which were part of a grant that vested in monthly installments until August 7, 2029. The shares were sold at a price of $41.23 each, and the stock has since increased to $45.53, nearing its 52-week high of $47.23.

Despite the recent sale, the company's shares have surged 46.8% over the past week. Heartflow reported strong financial results for Q2 2026, posting a narrower-than-expected loss and a 48% increase in revenue to $64.1 million. Analysts do not anticipate profitability this year, and the stock is currently considered overvalued. Rogers indirectly owns shares through several trusts, and he also holds 82,972 stock options with an exercise price of $19.00.